Using proteomic analysis, Blomme and colleagues (2016) [38] validated a novel exosomal protein, termed myoferlin, which is related to angiogenesis, metabolism reprogramming, and epithelial–mesenchymal transition in cancer [39]. Here, MYOF is linked to cancer.